# MS-Related Disability Worsening and Thalamic Volume Loss

> **NCT07753928** · — · ENROLLING_BY_INVITATION · sponsor: **Jung Diagnostics GmbH** · enrollment: 2400 (estimated)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Disease-Modifying Therapies (DMTs)

## Key facts

- **NCT ID:** NCT07753928
- **Lead sponsor:** Jung Diagnostics GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2022-07-01
- **Primary completion:** 2027-06-30
- **Final completion:** 2033-06-30
- **Target enrollment:** 2400 (ESTIMATED)
- **Last updated:** 2026-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07753928

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07753928, "MS-Related Disability Worsening and Thalamic Volume Loss". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07753928. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*